Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-22

Clinical Trial Update: A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating topical pirenzepine versus placebo for chemotherapy-induced peripheral neuropathy in oncology patients; the trial is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical pirenzepine (pirenzepine)

Snippet

Sponsor: WinSanTor, Inc | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING